News | November 21, 2025
Alkem launches globally acclaimed De Simone Probiotic in India, expands GI portfolio
The formulation is backed by over 80 clinical trials and 200 scientific publications
The formulation is backed by over 80 clinical trials and 200 scientific publications
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
Subscribe To Our Newsletter & Stay Updated
